← Open Payments lookup

FLORENCE AKOUEGNON: Open Payments

NPI 1083048748 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,652 in 93 payments from 17 companies in 2025. Trend: 2023 $163 · 2024 $1,960 · 2025 $2,652

Food & beverage: $2,640Education: $12
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$374
Neurocrine BioSciences, Inc.12$302
Vanda Pharmaceuticals Inc.9$286
Alkermes, Inc.9$262
Axsome Therapeutics, Inc.6$223
Teva Pharmaceuticals USA, Inc.5$188
Otsuka America Pharmaceutical, Inc.10$171
ABBVIE INC.8$149
Lilly USA, LLC5$149
Verona Pharma, Inc.1$124

Products named: CAPLYTA, INGREZZA, FANAPT, LYBALVI, Auvelity, AUSTEDO XR, REXULTI, VRAYLAR.

Industry payments across DE — which companies pay providers there.